Weiss, Doris <br/><br/>
Ustekinumab treatment in severe atopic dermatitis: Down-regulation of T-helper 2/22 expression.  [electronic resource] 

 -  Journal of the American Academy of Dermatology  Jan 2017 
 - 91-97.e3 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1097-6787 
<br/><br/><label>Standard No.: </label>10.1016/j.jaad.2016.07.047  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>CD4 Lymphocyte Count<br/>Cytokines--genetics<br/>Dermatitis, Atopic--drug therapy<br/>Dermatologic Agents--pharmacology<br/>Down-Regulation--drug effects<br/>Female<br/>Gene Expression--drug effects<br/>Humans<br/>Langerhans Cells--drug effects<br/>Male<br/>Mast Cells--drug effects<br/>Middle Aged<br/>RNA, Messenger--metabolism<br/>Severity of Illness Index<br/>T-Lymphocytes, Cytotoxic--drug effects<br/>Th1 Cells--metabolism<br/>Th17 Cells--metabolism<br/>Th2 Cells--drug effects<br/>Ustekinumab--pharmacokinetics